European Association of Dermato-Oncology 15th European Post-Chicago Melanoma Skin Cancer Meeting 2025

• Target Audience: dermatologists, oncologists
• Sample video: contact me for sample video
• Information:

We are excited to extend our warmest invitation to you for the upcoming Interdisciplinary Global Conference on News in Melanoma/Skin Cancer “European Post Chicago Meeting” in 2025. After many successful years in Munich, we are thrilled to announce that our event will be moving to the vibrant city of Hamburg, Germany.

Our move to Hamburg opens a new chapter for the conference. In this dynamic and historic city, we will continue our tradition of lively interaction among clinicians, researchers, and industry representatives. The 2025 conference will feature international key opinion leaders who will share cutting-edge research, present the latest clinical trial results, and engage in stimulating discussions on emerging therapies.

We look forward to welcoming you to Hamburg, where you will not only gain valuable scientific knowledge but also have the opportunity to connect with peers in a warm and familiar setting.

Dermatologists and oncologists involved in skin cancer diagnosis and treatment

Clinical researchers and translational scientists focused on melanoma and non-melanoma skin cancers

Pharmaceutical and biotech professionals working on immunotherapies, targeted therapies, and diagnostics

Healthcare professionals interested in the latest clinical trial data and therapeutic strategies

Medical trainees and fellows seeking updates on evidence-based practices in dermato-oncology

The event fosters interdisciplinary exchange and features international key opinion leaders, making it a hub for cutting-edge research and clinical insights.

• Topics:

CLOSING REMARKS.mp4

KEYNOTE LECTURE I.mp4

KEYNOTE LECTURE II.mp4

KEYNOTE LECTURE III.mp4

LUNCH SATELLITE SYMPOSIUM V.mp4

Opening Of The Conference.mp4

PARALLEL SYMPOSIUM I Registry data and studies Update 2025.mp4

PARALLEL SYMPOSIUM II Cutaneous T-cell lymphoma (CTCL).mp4

PARALLEL SYMPOSIUM III Complex melanoma cases.mp4

PARALLEL SYMPOSIUM IV Complex non-melanoma cases.mp4

SATELLITE SYMPOSIUM I.mp4

SATELLITE SYMPOSIUM II.mp4

SATELLITE SYMPOSIUM III.mp4

SATELLITE SYMPOSIUM IV.mp4

SATELLITE SYMPOSIUM VI.mp4

SYMPOSIUM I My personal highlights at ASCO 2025.mp4

SYMPOSIUM II Attacking tumor cells.mp4

SYMPOSIUM III Prognostic and predictive biomarkers.mp4

SYMPOSIUM IV Neoadjuvant perioperative treatment for skin cancer.mp4

SYMPOSIUM IX Is adjuvant treatment for melanoma dead.mp4

SYMPOSIUM V Adverse event management for ICI.mp4

SYMPOSIUM VI Adjuvant treatment of melanoma.mp4

SYMPOSIUM VII What’s new in guidelines and studies for….mp4

SYMPOSIUM VIII ImmTACs novel bi-specific agents for metastatic uveal and cutaneous melanomas.mp4

SYMPOSIUM X Melanoma survivorship.mp4